Patient remains pain-free three years after knee hydrogel treatment
A patient reports sustained pain relief and improved function nearly three years after receiving a hydrogel injection for knee osteoarthritis. The treatment has now been administered to over 20,000 individuals.
Joint Operations Medical GmbH has reported on a patient who continues to experience relief from knee pain and improved mobility nearly three years after receiving Arthrosamid treatment. The previously company director, 63, underwent the hydrogel injection in both knees in 2023.
He stated that the treatment resulted in a complete disappearance of pain and stiffness, restoring significant flexibility. The individual has since advocated for the treatment among friends and fellow golfers suffering from similar knee osteoarthritis issues.
Arthrosamid, a hydrogel injection designed to treat knee osteoarthritis, has been administered to over 20,000 patients across more than 400 clinics in the UK, Europe, Canada, and New Zealand as of January 2026. The company highlights the treatment's potential to restore quality of life for individuals affected by knee joint degeneration.